The Antimicrobial CLAVE is the first antimicrobial connector with dedicated internal fluid path technology. The same features that make the CLAVE the least likely to transmit bacteria over any other brand, now has the added feature of an antimicrobial additive.

CLAVE is the only connector which has been proven to reduce intraluminal catheter colonization in a randomized clinical trial. The reversed, split-septum technology and dedicated internal fluid path are the heart of what makes the CLAVE least likely to transmit bacteria than any other brand.

ICU Medical developed the Antimicrobial CLAVE to enhance the dedicated internal fluid path and further reduce the risk of bacterial ingress into the catheter. Ionic silver has been infused into all fluid path contact components which includes the internal cannula and split septum seal.

The Antimicrobial CLAVE provides at least a 4-log bacterial kill rate for a continuous 96-hour use life. This method of manufacturing eliminates the risk of the antimicrobial additive scraping or wearing away over time and repeated use.

• Significant reduction in bacterial counts for a continued 96-hour use life on the surface of the septum.
• Greater than a 4-log kill and a 99.99% reduction rate for Gram positive and Gram negative strains.

The Antimicrobial MicroCLAVE was proven effective with four gram positive and two gram negative bacterial strains.

• Staphylococcus aureus
• Staphylococcus epidermidis
• Methicillin resistant Staphylococcus aureus - MRSA
• Enterococcus faecalis- VRE
• Pseudomonas aeruginosa
• Klebsiella pneumoniae

Flowrate:
Deadspace:
Backpressure:
Functional Activations:
Other Features:

185mL / min.
0.06mL
75psig+
600
Latex Free